{"data":{"id":"us-dc/d.c.-code-7-3212","jurisdiction":"us-dc","citation":"D.C. Code § 7-3212","heading":"Opioid Abatement Advisory Commission.","body":"(a)\nThere is established an Opioid Abatement Advisory Commission.\n\n(b)\nThe purpose of the Commission shall be to:\n(1)\nEnsure that the monies the District receives and deposits into the Fund are appropriately expended on evidence-based and evidence-informed harm reduction, prevention, recovery, and treatment activities, practices, programs, services, supports, and strategies for opioid use disorder and co-occurring substance use and mental health disorders;\n(2)\nPrioritize and facilitate public involvement, accountability, and transparency in allocating and accounting for these monies; and\n(3)\nEnsure that the monies the District receives and deposits into the Fund have the effect of preventing, treating, and reducing opioid use disorder and co-occurring substance use and mental health disorders and reducing fatalities.\n\n(c)\nThe Commission shall be composed of 15 members as follows:\n(1)\nThe Director of the Department of Health, or their designee;\n(2)\nThe Director of the Department of Behavioral Health, or their designee;\n(3)\nThe Attorney General, or their designee;\n(4)\nThe Director of the Department of Health Care Finance, or their designee;\n(5)\nThe Chairperson of the Council committee with jurisdiction over health matters, or their designee;\n(6)\nThree members appointed by the Mayor, with the following qualifications:\n(A)\nOne member who is a current opioid user or who has lived experience with opioid use disorder and co-occurring mental health or substance use disorders and recovery;\n(B)\nOne member with expertise in either public health policy, public health research, or health equity with a demonstrated understanding of opioid use, harm reduction, treatment, and recovery systems; and\n(C)\nOne member who has provided direct treatment services related to prevention, harm reduction, substance use disorder, or recovery, with a preference for individuals who have worked with populations disproportionately impacted by the opioid crisis, including Black residents, unhoused individuals, and justice-involved populations;\n(7)\nThree members appointed by the Chairman of the Council, with the following qualifications:\n(A)\nOne member who is a current opioid user or who has lived experience with opioid use disorder and co-occurring mental health or substance use disorders and recovery;\n(B)\nOne member with expertise in addiction medicine and co-occurring substance use, and mental health disorders; and\n(C)\nOne member who has provided direct treatment services related to prevention, harm reduction, substance use disorder, or recovery, with a preference for individuals who have worked with populations disproportionately impacted by the opioid crisis, including Black residents, unhoused individuals, and justice-involved populations;\n(8)\nOne representative from the District of Columbia Behavioral Health Association;\n(9)\nOne representative from the Medical Society of the District of Columbia;\n(10)\nOne representative from the District of Columbia Primary Care Association; and\n(11)\nOne representative from the District of Columbia Hospital Association.\n\n(d)\n(1)\nThe Commission shall elect a Chair or Co-Chairs from among its members, who shall serve for a term of 2 years and may be appointed to no more than 2 consecutive terms.\n(2)\nThe Commission shall consider the following qualifications in electing a Chair or Co-Chair:\n(A)\nDemonstrated experience leading commissions, advisory bodies, boards, task forces, or large stakeholder groups;\n(B)\nAbility to facilitate meetings, manage group processes, and foster collaboration and consensus across sectors;\n(C)\nExperience collaborating with District government agencies; and\n(D)\nA preference that at least one Co-Chair, if applicable, be a person with lived experience related to substance use disorder or a representative of a non-governmental organization engaged in prevention, treatment, recovery, or harm reduction.\n\n(e)\n(1)\nEach member appointed pursuant to subsection (c)(6) and (7) of this section shall serve a 3-year term; except, that:\n(2)\nMembers shall serve:\n(A)\nFollowing the expiration of their terms until their successors have been appointed;\n(B)\nFor a maximum of 2 full terms, with partial term service not counted toward this maximum; and\n(C)\nWithout compensation; provided, that they shall be reimbursed for necessary expenses incurred in carrying out Commission duties.\n(3)\nVacancies shall be filled in the same manner as the original appointment for the remainder of the term.\n\n(f)\nThe Commission shall hold public meetings at least quarterly, with meetings called by the Chair or a majority of Commission members. All Commission meetings shall be subject to subchapter IV of Chapter 5 of Title 2.\n\n(g)\nA majority of the Commission's members shall constitute a quorum, and actions of the Commission shall be taken by an affirmative vote of a majority of the members in attendance at a meeting where a quorum is present. Members may attend in person or remotely through audio or audiovisual means.\n\n(g-1)\nThe Commission shall regularly engage with, and seek input from, the following agencies to support informed decision-making and to ensure that the Commission's work aligns with District-wide policies, programs, and service-delivery efforts:\n(1)\nThe Deputy Mayor for Health and Human Services;\n(2)\nThe Deputy Mayor for Public Safety and Justice;\n(3)\nThe Director of the Department of Human Services; and\n(4)\nThe Chief Medical Examiner.\n\n(h)\nThe Commission shall have the power and duty to:\n(1)\nEstablish procedures for the Commission's operations, including establishing expert driven subcommittees; and\n(2)\nMake recommendations to the Mayor and Council regarding:\n(A)\nDistrict-wide goals, objectives, and performance indicators relating to:\n(i)\nPrevention, recovery, treatment, and harm reduction infrastructure, activities, practices, programs, services, supports, and strategies for opioid use disorder and co-occurring substance use and mental health disorders;\n(ii)\nReducing disparities in access to prevention, recovery, treatment, and harm reduction infrastructure, activities, practices, programs, services, supports, and strategies; and\n(iii)\nImproving outcomes and reducing mortality in traditionally underserved populations, including for communities of color and current or formerly incarcerated individuals, with regard to prevention, recovery, treatment, and harm reduction infrastructure, activities, practices, programs, services, supports, and strategies;\n(B)\nGoverning principles, policies, and procedures for the application for and awarding of monies and grants from the Fund;\n(C)\nAwards of monies and grants from the Fund;\n(D)\nThe performance and outcomes of Fund awardees and grantees;\n(E)\nManagement of the Fund; and\n(F)\nAny changes to the Fund's purposes.\n\n(i)\nThe Commission's recommendations for the awarding of monies and grants pursuant to subsection (h)(2)(C) of this section shall include the consideration of:\n(1)\nThe number of individuals, per capita, with an opioid use disorder, and the number of overdose deaths per capita, in the area that a prospective awardee or grantee seeks to serve;\n(2)\nDisparities in access to care and health outcomes in the area that a prospective awardee or grantee seeks to serve; and\n(3)\nThe infrastructure, activities, practices, programs, services, supports, and strategies currently available to individuals with an opioid use disorder in an area that a prospective awardee or grantee seeks to serve.","path":["Title 7. Human Health Care and Safety.","Chapter 32. Opioid Overdose Treatment and Prevention.","Subchapter II. Opioid Litigation Proceeds."],"source_url":"https://code.dccouncil.gov/us/dc/council/code/sections/7-3212","current_through":"2026-08-20 (D.C. Law 26-175)","vintage":"","retrieved_at":"2026-08-29T05:44:07Z","sha256":"8f33626ee3d517de7f5ba58a6788b74f6d5949cf10948b6d5bffa5e314e76132","source_id":"us-dc","stale":false,"prev":"us-dc/d.c.-code-7-3211","next":"us-dc/d.c.-code-7-3213"},"notice":"GroundRules: Original legal text. Not legal advice."}